MUC5AC and chronic obstructive pulmonary disease: Similarly, airway epithelial cells from patients with asthma and COPD have higher expression levels of MUC5AC than those from healthy individuals (49–51), so screens to identify compounds to reduce goblet cell metaplasia or mucous hypersecretion would also be feasible in disease contexts.